In a move that promotes open science, Johnson & Johnson (J&J) announced last week that it will make all of its clinical trial data publicly available.
Changing the Level of One Gene Increases Mouse Lifespan 20 Percent
August 29, 2013 | by
By lowering the expression of a single gene, researchers at the National Institutes of Health have extended the average lifespan of a group of mice by about 20 percent — the equivalent of raising the average human lifespan by 16 years, from 79 to 95. This study appears in the August 29th edition of Cell Reports [1].
Targeted Brain Stimulation a Promising Treatment for Addiction
April 4, 2013 | by
Could drug addiction treatment of the future be as simple as an on/off switch in the brain? A study in rats has found that stimulating a key part of the brain reduces compulsive cocaine-seeking and suggests the possibility of changing addictive behavior generally [1]. The study, published in the journal Nature, was conducted by scientists at the Intramural Research Program of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and the University of California, San Francisco.
Testing for Parkinson’s Disease Over the Phone
March 11, 2013 | by
This week is Brain Awareness Week (BAW), an annual observance dedicated to raising public awareness about the progress and benefits of brain research. Coordinated by the Dana Alliance for Brain Initiatives and the European Dana Alliance for the Brain, every March, BAW unites the efforts of partner organizations around the world in a week-long celebration of the brain.
2012: Banner Year for New Drugs
February 12, 2013 | by
Fueled by new cancer therapeutics, last year the annual new molecular and biological entity approval count from the U.S. Food and Drug Administration (FDA) saw its highest year since 1997. One-third of the novel products approved by the FDA’s Center for Drug Evaluation and Research (CDER) are used to treat cancers of the blood, breast, colon, prostate, skin and thyroid.
